Zusammenfassung
Tissue factor pathway inhibitor (TFPI) wird nach Hemmung des Faktors Xa im nächsten Schritt im Komplex mit diesem zum Inhibitor des aktivierten Faktors VII. So ist TFPI zusammen mit Faktor Xa, Vlla und Thromboplastin (Tissue factor) ein endogener Inhibitor der extrinsischen Gerinnungskaskade und verlängert im Plasma die Gerinnungszeit.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abumiya T, Nakamura S, Takenaka A, Takenaka 0, Yoshikuni Y, Miyamoto S, Kimura T, Enjyoji K, Kato H (1994) Response of plasma tissue factor pathway inhibitor to diet-induced hypercholesterolemia in crab-eating monkeys. Atherioscler Thromb 14 3:483–488
Ariens RAS, Coppola R, Potenza I, Mannucci PM (1995) The increase with age of the components of the tissue factor coagulation pathways is gender-dependent. Blood Coagul Fibrinol 6:388–394
Brinkmann T, Kähnert H, Prohaska W, Nordfang O, Kleesiek K (1994) Synthesis of tissue factor pathway inhibitor in human synovial cells and chrondrocytes makes joints the predilected site of bleeding in haemophiliacs. Eur J Clin Chem Clin Biochem 32:313–317
Broze GJ, Girard TJ, Novotny WF (1990) Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemisky 29:7539–7546
Chitolie A, Hudson M, Wakefield AJ, Riddell A, Lee CA, Pounder RE (1993) Tissue factor pathway inhibitor (TFPI) and factor VII in inflammatory bowel disease (IBD). Thromb Haemostas. THHADQ 69 6:1081
Erhardtsen E, Ezban M, Madsen MT, Diness V, Glazer S, Hedner U, Nordfang O (1995) Blocking of tissue factor pathway inhibitor (TFPI) shortens bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinol 6:388–395
Fareed J, Callas DD, Hoppensteadt D, Bernes EW (1995) Tissue factor antigen levels in various biological fluids. Blood Coagul Fibrinol 6 1:S32–S36
Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, Nordoy (1994) Tissue factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma. Atherioscler Thromb 14 2:223–229
Hedner U (1990) Factor Vlla in the treatment of hemophilia. Blood Coagul Fibrinol 1:307–317
Imubind Total TFPI ELISA Kit, Product #849, American Diagnostica Inc ADI94-06-22
Kalbas M, Hinz U, Müller-Berghaus G (1993) Heparin-induced release of tissue factor pathway inhibitor (TFPI) by human endothelial and malignant cells. Thromb Haemostas THHADQ 69 6:681
Mesters RM, Kienast J, Ostermann H, Loo J vande (1993) Tissue factor pathway inhibitor (TFPI) in septicemia: a prospective study in neutropenic patients. Thromb Haemostas THHADQ 696:1198
Sandset PM, Larsen ML, Abildgaard U, Lindahl AK, Odegard OR (1991) Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels in the normal population and relation to cholesterol. Blood Coagul Fibrinol 2:425–433
Wendisch J, Weissbach G, Harenberg J (1993) The behaviour of the tissue factor pathway inhibitor (TFPI) in healthy and sick children. Thromb Haemostas THHADQ 69 6:682
Zitou D, Bara L, Basdevant A, Guy-Grand B, Samama M (1993) Human hyperglyceridemia is associated with an increase of F VII coagulant activity and a decrease of TFPI activity. Thromb Haemostas THHADQ 69 6:561
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schulz, R., Scharrer, I., Hovy, L. (1997). Tissue Factor Pathway Inhibitor (TFPI) in der Synovialflüssigkeit großer Gelenke. In: 26. Hämophilie-Symposion 1995. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60418-8_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-60418-8_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61101-1
Online ISBN: 978-3-642-60418-8
eBook Packages: Springer Book Archive